OICHARTS
8 AMThe 8 AM report →

LALPATHLAB

Dr. Lal Path Labs Ltd. · NSE · INE600L01024 · 272 sessions on record
₹2,005.10▲ +18.10 · +0.9%from ₹1,987.00 the session before · 1 Oct 2026 close · NSE end of day
Open
₹1,975.70
High
₹2,027.60
Low
₹1,936.20
Day's range
₹914.6% of the previous close
VWAP
₹1,998.68close +0.32% from it
Volume, shares
5.4 L1.61× the 20-session average
Turnover, ₹ crore
110
Trades
68,0008.0 shares per trade
Previous close
₹1,987.00+18.10 to the close
Price band, next session
₹1,804.60 – ₹2,205.6010% either side of the close · dynamic, widened in 5% steps when hit
Day range75% of the way up
₹1,936.20₹2,027.60
52-week range36% of the way up
₹1,272.60 23 Mar₹3,309.20 19 Nov

−39% from the high · +58% from the low

Futures and options

No derivatives listed on LALPATHLAB

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close
272 sessions on file · from 28 Aug
LALPATHLAB close and futures open interest over the last 126 sessions, with Nifty 50 rebased to the first close130917922276axis spans 74%Nifty 50LALPATHLAB1 Apr6 Jul1 Oct126 sessions from 1 Apr to 1 Oct; the price axis spans 74 percent.

The market after the news

close against the last close before each bulletin · Nifty 50 over the same sessions

After the last 3 bulletins, LALPATHLAB closed higher five sessions later in 3 of 3.

Close after each bulletin on the day, one session later and five sessions later, with Nifty 50 and futures open interest
BulletinDay of the news1 session later5 sessions laterFutures OI on the day
24 JulDr. Lal PathLabs Q1 FY27 revenue up 19% YoY▲ +3.9%Nifty +1.0% · +2.9 pp▲ +2.6%Nifty +0.9% · +1.7 pp▲ +8.0%Nifty +4.2% · +3.8 pp—
4 MayDr. Lal PathLabs acquires 100% stake in Shahbazkers Centre▼ −2.3%Nifty −0.4% · −2.0 pp▲ +0.8%Nifty +0.9% · −0.1 pp▲ +0.9%Nifty −3.1% · +3.9 pp—
30 JanLalPathLab reports revenue growth and bonus share issue▲ +1.4%Nifty −2.0% · +3.4 pp▲ +0.6%Nifty −0.9% · +1.5 pp▲ +2.4%Nifty +1.5% · +0.9 pp—
3 of 3 bulletins

Quarterly results

consolidated · latest filed 24 Jul, 05:58 pm IST · NSE filings

Revenue ₹798 cr; profit ₹171 cr in the Jun 2026 quarter, consolidated.

Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of LALPATHLAB on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue ₹ crRevenue YoYProfit ₹ crProfit YoYEPS ₹Market on the day
Jun 2026filed 24 Jul₹798 cr—₹171 cr—10.13▲ +3.9%Nifty +1.0% · +2.9 pp
Mar 2026filed 30 Apr · audited₹703 cr—₹132 cr—7.85▲ +15.1%Nifty +0.5% · +14.6 pp

Fundamentals

consolidated · filings to Jun 2026 · close ₹2,005.10 on 1 Oct

13 times book value, a 0.97% dividend yield, market cap ₹34,000 cr.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
₹34,000 cron 1 Oct · free float ₹16,000 cr
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
13consolidated · balance sheet to Mar 2026
Book value a share
₹151.40consolidated · balance sheet to Mar 2026 · over NSE's share count
Debt to equity
0.00borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity
—needs two filed balance sheets
Dividend yield
0.97%₹19.50 a share in 365 days
Face value
₹10a share
Shares outstanding
17 cron 1 Oct
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed
PeersBSE sub-group Healthcare Service Provider · F&O stocks with filings on record · industry P/E needs two stocks with trailing profit and a market cap
Stocks in the BSE sub-group Healthcare Service Provider with market cap, price to earnings and price to book
StockMarket cap ₹P/EP/BClose ₹
LALPATHLABDr. Lal Path Labs Ltd.34,000 cron 1 Oct—13₹2,005.10
VIJAYAVijaya Diagnostic Centre Limited15,000 cron 1 Oct—15₹1,428.00
METROPOLISMetropolis Healthcare Limited11,000 cron 1 Oct—7.3₹537.90
THYROCAREThyrocare Technologies Limited8,500 cron 1 Oct—14₹533.60
NEPHROPLUSNephrocare Health Services Limited6,500 cron 1 Oct—5.8₹648.95
SURAKSHASuraksha Diagnostic Limited1,800 cron 1 Oct—7.5₹350.15
KRSNAAKrsnaa Diagnostics Limited1,800 cron 1 Oct—1.8₹554.85
3BBLACKBIO3B Blackbio Dx Limited1,400 cron 1 Oct——₹1,646.80
ONEGLOBALOne Global Service Provider Limited1,000 cron 1 Oct——₹525.40
HEALTHXHealth X Platform Limited870 cron 1 Oct—1.1₹273.00
GAUDIUMIVFGaudium IVF and Women Health Limited800 cron 1 Oct—5.2₹109.50

Shareholding

quarter to 30 Jun · none pledged · NSE filings

Promoters hold 53.2%, foreign portfolio investors 17.4%, mutual funds 18.8% and insurance companies 2.4%, as filed for the quarter to 30 Jun.

By category, last 2 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of LALPATHLAB by category over the last 2 quarters with the change against the previous quarter
Category30 Jun31 Mar
Promoters53.19▼ −0.02 pp53.21
Foreign portfolio investors17.35▲ +0.17 pp17.18
Mutual funds18.79▲ +0.17 pp18.62
Insurance companies2.37▲ +0.04 pp2.33
Banks and financial institutions0.43▲ +0.01 pp0.42
Individual investors6.79▼ −0.32 pp7.11
Bodies corporate0.47▼ −0.05 pp0.52
Government0.010.00 pp0.01
Employee trusts0.38▲ +0.04 pp0.34
Others0.22▼ −0.04 pp0.26

Corporate actions

next results meeting 4 Nov · NSE and BSE records

Nothing upcoming on record; the board meets for results on 4 Nov 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios
Corporate actions of LALPATHLAB, upcoming first, then the most recent
Ex-dateActionAmount or ratioRecord dateSource
recent
30 Jul 2026dividend₹5.0030 Jul 2026NSE
25 Jun 2026dividend₹4.0026 Jun 2026NSE
5 Feb 2026dividend₹3.505 Feb 2026NSE
19 Dec 2025bonus1:119 Dec 2025NSE
7 Nov 2025dividend₹7.007 Nov 2025NSE
6 Aug 2025dividend₹6.006 Aug 2025NSE
6 Jun 2025dividend₹6.006 Jun 2025NSE
5 Feb 2025dividend₹6.005 Feb 2025NSE
Calendaras notified to the exchange
Next results
4 Nov 2026Financial Results/Other business matters To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Dividends in 365 days
₹19.50a share · ex-dates inside the year
Last dividend
₹5.00ex-date 30 Jul 2026

Price history

272 sessions on record · to 1 Oct · NSE end of day

LALPATHLAB is +4.6% over 20 sessions against Nifty's −6.2%, 39% below its 52-week high, realised volatility 18% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
WindowFrom ₹LALPATHLAB %Nifty 50 %Difference pp
250 sessionssince 26 Sept₹3,194.36▼ −37%▼ −9.1%−28
120 sessionssince 9 Apr₹1,395.24▲ +44%▼ −5.7%+49
60 sessionssince 8 Jul₹1,653.55▲ +21%▼ −6.1%+27
20 sessionssince 2 Sept₹1,916.19▲ +4.6%▼ −6.2%+11
5 sessionssince 24 Sept₹1,961.36▲ +2.2%▼ −2.8%+5.0
1 sessionsince 30 Sept₹1,987.02▲ +0.91%▼ −0.88%+1.8
Averages of the closeclose against each average
5-session average
₹1,967.38close +1.9% from it
20-session average
₹1,926.95close +4.1% from it
50-session average
₹1,907.39close +5.1% from it
200-session average
₹1,636.23close +23% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹683.4% of the close
Average day's range, 20
₹653.2% of the close
Volume against 20 sessions
1.61×5.4 L vs 3.5 L average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
18%≈ ±1.1% a session · moved more than that on 7 of 20
Realised volatility, 60
22%≈ ±1.4% a session · moved more than that on 16 of 60
Realised volatility, 250
76%≈ ±4.8% a session · moved more than that on 3 of 250
Beta to Nifty, 60
0.09moved with Nifty on 29 of 60 sessions
Beta to Nifty, 250
0.21moved with Nifty on 146 of 250 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
11 up · 9 downof 20
Last 60 sessions
34 up · 26 downof 60
Last 250 sessions
121 up · 129 downof 250
Best session, 250
▲ +15%4 May
Worst session, 250
▼ −50%19 Dec

Dr. Lal Path Labs Ltd. is in 19 NSE indices

all 19 indices

3 bulletins on LALPATHLAB

latest 24 Jul 2026

About Dr. Lal Path Labs Ltd.

exchange masters as of 18 Sept 2026 · classification by BSE
Company
Dr. Lal Path Labs Ltd.
Exchange
NSE · BSE 539524, group A
Listed on NSE
23 Dec 2015
Classification
Healthcare › Healthcare Services › Healthcare Service Provider
Index
BSE 500
Face value
₹10 a share
ISIN
INE600L01024
Sessions on record
272
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
2 Oct, 12:07 am IST
Bulletins
3 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.